Ending Eclampsia, September 2019 Exploring ways to integrate the two components of the Ending Eclampsia Model within existing training systems should be explored to further reduce costs. This implementation cost analysis serves as a starting point for those considering implementation…
Tag Archive for treatment
Primary Healthcare for Pre-eclampsia and Eclampsia Model in Nigeria: A cost analysis
Ending Eclampsia, September 2019 This implementation cost analysis serves as a starting point for those considering implementation of different components of the PHC PE/E Model. Ways to consolidate costs of implementing the five components of the Nigeria Ending Eclampsia intervention…
Retrospective cohort study: Clinical presentation and outcomes of pre-eclampsia and eclampsia at Kenyatta National Hospital, Nairobi, Kenya
Ending Eclampsia, January 2018 Researchers examined the clinical presentation at admission, management of complications, and maternal and newborn health outcomes in the maternity unit at Kenyatta National Hospital to ascertain any differences between health outcomes of early- and late-onset pre-eclampsia.
Addressing barriers to quality of underutilized commodities and services for prevention and management of pre-eclampsia and eclampsia in Kenya
Ending Eclampsia, August 2018 The study assessed the policy and health system environment for PE/E diagnosis, referral, and treatment, including potential supply chain bottlenecks; investigated similarities and differences in PE/E knowledge, attitudes, and care-seeking behaviors among providers, women and community…
Exploring barriers and opportunities for pre-eclampsia and eclampsia prevention and management in Ethiopia
Ending Eclampsia, July 2018 This report presents qualitative findings on the policy and health systems environment related to PE/E prevention and management, bottlenecks in Ethiopia’s supply chain, the barriers for provision/utilization of prevention and management for PE/E, and the similarities…
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial
The Lancet, August 2019 Results showed that alll oral antihypertensives reduced blood pressure to the reference range in most women. As single drugs, nifedipine retard use resulted in a greater frequency of primary outcome attainment than labetalol or methyldopa use.…
What is preeclampsia and how widespread is it?
By Dr. Amanda Henry, The George Institute Preeclampsia is a pregnancy-related condition characterised by high blood pressure and evidence of other effects on organs of the pregnant woman and her baby, such as protein in the urine, abnormal blood tests…
Findings from post-intervention analysis of pre-eclampsia/eclampsia in Kogi State, Nigeria
Ending Eclampsia, 2018 This brief presents study findings from Cross River State on post-intervention landscape changes in programmatic and policy support for PE/E prevention and treatment; PHC facilities’ capacity to manage PE/E; provider knowledge and competence in preventing, detecting, and managing…
Findings from post-intervention analysis of pre-eclampsia/eclampsia in Ebonyi State, Nigeria
Ending Eclampsia, 2018 This brief presents study findings from Cross River State, Nigeria on post-intervention landscape changes in programmatic and policy support for PE/E prevention and treatment; PHC facilities’ capacity to manage PE/E; provider knowledge and competence in preventing, detecting, and…
Primary Health Care-Preeclampsia/Eclampsia Plus Model
Ending Eclampsia, 2018 Starting in 2016, Ending Eclampsia initiated six additional implementation research studies in three countries – Bangladesh, Nigeria, Pakistan – to identify and assess additional components that, in conjunction with the Core Model, can further improve prevention, detection,…
